MariMed (OTC:MRMD – Get Free Report) and Exactus (OTCMKTS:EXDI – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.
Volatility and Risk
MariMed has a beta of 2.99, meaning that its share price is 199% more volatile than the S&P 500. Comparatively, Exactus has a beta of 4.21, meaning that its share price is 321% more volatile than the S&P 500.
Earnings & Valuation
This table compares MariMed and Exactus”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
MariMed | $148.60 million | 0.19 | -$16.03 million | ($0.03) | -2.42 |
Exactus | $2.07 million | 0.00 | -$9.46 million | N/A | N/A |
Exactus has lower revenue, but higher earnings than MariMed.
Analyst Ratings
This is a breakdown of recent recommendations for MariMed and Exactus, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
MariMed | 0 | 0 | 0 | 1 | 4.00 |
Exactus | 0 | 0 | 0 | 0 | 0.00 |
Given Exactus’ higher probable upside, analysts clearly believe Exactus is more favorable than MariMed.
Institutional & Insider Ownership
0.2% of MariMed shares are held by institutional investors. Comparatively, 0.1% of Exactus shares are held by institutional investors. 19.0% of MariMed shares are held by company insiders. Comparatively, 65.0% of Exactus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability
This table compares MariMed and Exactus’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
MariMed | -8.95% | 1.58% | 0.53% |
Exactus | N/A | -3,272.69% | -185.29% |
Summary
MariMed beats Exactus on 7 of the 12 factors compared between the two stocks.
About MariMed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
About Exactus
Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.